Edaravone Dexborneol regulates the endothelial PPARγ-PON1 axis to inhibit high-cholesterol-induced atherosclerosis
Clin Sci (Lond). 2026 Jul 6:CS20260830. doi: 10.1042/CS20260830. Online ahead of print.ABSTRACTAtherosclerosis, a primary cause of ischemic diseases, is driven by excessive oxidative stress. Edaravone Dexborneol, a clinically used antioxidant, has demonstrated potent protective effects in cerebral i

